Kindstar Globalgene Technology (HKSE:09960) PE Ratio without NRI: At Loss (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09960 Kindstar Globalgene Technology Inc HKSE:09960
69 GF Score
Price HK$1.00
GF Value HK$1.06
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Kindstar Globalgene Technology PE Ratio without NRI?

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-08-31), Kindstar Globalgene Technology's share price is HK$1.00. Kindstar Globalgene Technology's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.07. Therefore, Kindstar Globalgene Technology's PE Ratio without NRI for today is At Loss.

During the past 8 years, Kindstar Globalgene Technology's highest PE Ratio without NRI was 105.00. The lowest was 0.00. And the median was 53.85.

Kindstar Globalgene Technology's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.07.

As of today (2026-08-31), Kindstar Globalgene Technology's share price is HK$1.00. Kindstar Globalgene Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.07. Therefore, Kindstar Globalgene Technology's PE Ratio (TTM) for today is At Loss.

During the past years, Kindstar Globalgene Technology's highest PE Ratio (TTM) was 37.17. The lowest was 0.00. And the median was 23.90.

Kindstar Globalgene Technology's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.07.

Kindstar Globalgene Technology's EPS (Basic) for the six months ended in Dec. 2025 was HK$-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.07.


Kindstar Globalgene Technology  (HKSE:09960) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Kindstar Globalgene Technology PE Ratio without NRI Related Terms


Kindstar Globalgene Technology PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Kindstar Globalgene Technology's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kindstar Globalgene Technology PE Ratio without NRI Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial At Loss 17.76 64.62 73.75 At Loss

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.62 At Loss 73.75 At Loss At Loss

HKSE:09960 vs TMO, DHR, NTRA: PE Ratio without NRI Comparison

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's PE Ratio without NRI falls into.


HKSE:09960
69GF Score
Kindstar Globalgene Technology Inc HKSE:09960
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kindstar Globalgene Technology PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Kindstar Globalgene Technology's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=1.00/-0.065
=-15.38(At Loss)

Kindstar Globalgene Technology's Share Price of today is HK$1.00.
For company reported semi-annually, Kindstar Globalgene Technology's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Is Kindstar Globalgene Technology (HKSE:09960) Overvalued in 2026?

Based on GuruFocus' analysis, Kindstar Globalgene Technology stock appears to be undervalued. The current stock price of HK$1.00 is trading 5.7% below its estimated GF Value™ of HK$1.06. GuruFocus considers Kindstar Globalgene Technology to be Fairly Valued.

Key valuation signals for HKSE:09960:

  • PE Ratio without NRI: At Loss
  • GF Value™: HK$1.06 vs. price of HK$1.00 (5.7% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kindstar Globalgene Technology Business Description

Address Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is engaged in the provision of clinical testing services in China. It operates in nine segments: Hematology testing segment includes testing services related to blood diseases; Genetic diseases and rare diseases segment includes testing services for rare diseases; Infectious diseases segment includes testing services from the infection department; Oncology segment includes testing related to oncology diseases; Neurology segment includes testing services related to neurological diseases undertaken by the Group; Maternity-related diseases segment includes testing services related to maternity; Routine testing segment conducts routine tests for the doctors daily diagnoses; CROs & R&D project segment includes research & develop services; & others segment.
69GF Score

Get the complete analysis for HKSE:09960

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.00
Price
HK$1.06
GF Value